Format

Send to

Choose Destination
Arch Biochem Biophys. 2014 Mar 15;546:33-40. doi: 10.1016/j.abb.2014.01.026. Epub 2014 Feb 3.

Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscs.

Author information

1
Department of Structural Biology, The State University of New York at Buffalo, Buffalo, NY 14203, USA.
2
Department of Comparative Biosciences, University of Illinois Urbana-Champaign, Urbana, IL 61802, USA; Department of Biochemistry, University of Illinois Urbana-Champaign, Urbana, IL 61802, USA; Department of Bioengineering and Beckman Institute for Advanced Science and Technology, University of Illinois Urbana-Champaign, Urbana, IL 61802, USA.
3
New York Structural Biology Center, New York, NY 10027, USA.
4
Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University Medical School, Nashville, TN 37232, USA.
5
Department of Structural Biology, The State University of New York at Buffalo, Buffalo, NY 14203, USA; Hauptman-Woodward Medical Research Institute, Buffalo, NY 14203, USA. Electronic address: malkowski@hwi.buffalo.edu.

Abstract

Cyclooxygenases (COX-1 and COX-2) oxygenate arachidonic acid (AA) to generate prostaglandins. The enzymes associate with one leaflet of the membrane bilayer. We utilized nanodisc technology to investigate the function of human (hu) COX-2 and murine (mu) COX-2 in a lipid bilayer environment. huCOX-2 and muCOX-2 were incorporated into nanodiscs composed of POPC, POPS, DOPC, or DOPS phospholipids. Size-exclusion chromatography and negative stain electron microscopy confirm that a single COX-2 homodimer is incorporated into the nanodisc scaffold. Nanodisc-reconstituted COX-2 exhibited similar kinetic profiles for the oxygenation of AA, eicosapentaenoic acid, and 1-arachidonoyl glycerol compared to those derived using detergent solubilized enzyme. Moreover, changing the phospholipid composition of the nanodisc did not alter the ability of COX-2 to oxygenate AA or to be inhibited by various nonselective NSAIDs or celecoxib. The cyclooxygenase activity of nanodisc-reconstituted COX-2 was reduced by aspirin acetylation and potentiated by the nonsubstrate fatty acid palmitic acid to the same extent as detergent solubilized enzyme, independent of phospholipid composition. The stabilization and maintenance of activity afforded by the incorporation of the enzyme into nanodiscs generates a native-like lipid bilayer environment to pursue studies of COX utilizing solution-based techniques that are otherwise not tractable in the presence of detergents.

KEYWORDS:

Arachidonic acid; Aspirin; Cyclooxygenase; Nanodisc; Nonsteroidal anti-inflammatory drugs; Phospholipid

PMID:
24503478
PMCID:
PMC3967765
DOI:
10.1016/j.abb.2014.01.026
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center